Different cancer platelet count. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Blood Platelets Cell Line, Tumor Megakaryocytes Tumor Cells, Cultured Bone Marrow Platelet-Rich Plasma Leukocytes Cytoplasmic Granules Neutrophils Cells, Cultured

Organisms3

Mice, Nude Rabbits Mice, Inbred C57BL

Diseases55

Thrombocytopenia Neoplasms Thrombocytosis Purpura, Thrombocytopenic, Idiopathic Breast Neoplasms Lung Neoplasms Prostatic Neoplasms Purpura, Thrombocytopenic Ovarian Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Thrombosis Colorectal Neoplasms Disease Progression Disseminated Intravascular Coagulation Genetic Predisposition to Disease Thrombocythemia, Essential Hemorrhage HELLP Syndrome Cell Transformation, Neoplastic Blood Coagulation Disorders Carcinoma, Squamous Cell Stomach Neoplasms Adenocarcinoma Hypersplenism Pancreatic Neoplasms Pregnancy Complications, Hematologic Melanoma Platelet Storage Pool Deficiency Thrombocytopenia, Neonatal Alloimmune Glioblastoma Uterine Cervical Neoplasms Hemorrhagic Disorders Carcinoma Carcinoma, Non-Small-Cell Lung Liver Cirrhosis Urinary Bladder Neoplasms Neoplasm Recurrence, Local Liver Neoplasms Disease Models, Animal Primary Myelofibrosis Thrombasthenia Bernard-Soulier Syndrome Leukocytosis Hematologic Diseases Neutropenia Rectal Neoplasms Polycythemia Vera Leukemia Anemia, Aplastic Endometrial Neoplasms Blood Platelet Disorders Splenomegaly von Willebrand Diseases

Chemicals and Drugs67

Platelet Membrane Glycoproteins Platelet Factor 4 Platelet Glycoprotein GPIIb-IIIa Complex Antineoplastic Agents Platelet Glycoprotein GPIb-IX Complex Platelet Activating Factor Thrombopoietin Thrombin Antigens, Human Platelet Fibrinogen Adenosine Diphosphate Tumor Markers, Biological Neoplasm Proteins P-Selectin RNA, Messenger von Willebrand Factor MicroRNAs Antigens, Neoplasm Aspirin Receptors, Thrombopoietin Platelet Membrane Glycoprotein IIb RNA, Small Interfering Antibodies, Monoclonal RNA, Neoplasm Tumor Suppressor Protein p53 Thromboxane A2 Collagen Tumor Suppressor Proteins Platelet Factor 3 Heparin Recombinant Proteins Blood Coagulation Factors Cancer Vaccines Serotonin Ristocetin Biological Markers Hemoglobins Transcription Factors Immunoglobulins, Intravenous Receptors, Purinergic P2Y12 Anticoagulants Blood Proteins Pipecolic Acids Receptors, Estrogen Granulocyte Colony-Stimulating Factor Cyclophosphamide Receptor, erbB-2 Fluorouracil Hydrazines Cisplatin Oxyquinoline Fibrin Fibrinogen Degradation Products Crotalid Venoms Polyethylene Glycols DNA, Neoplasm Danazol Prostate-Specific Antigen Antibodies Fibrin Edetic Acid Paclitaxel Thromboxanes Sulfinpyrazone Immunoglobulin G Calcium Membrane Proteins Tamoxifen

Analytical, Diagnostic and Therapeutic Techniques and Equipment74

Platelet Count Platelet Transfusion Blood Cell Count Leukocyte Count Platelet Function Tests Bleeding Time Prognosis Early Detection of Cancer Splenectomy Gene Expression Profiling Retrospective Studies Risk Factors CD4 Lymphocyte Count Erythrocyte Count Flow Cytometry Prospective Studies Reverse Transcriptase Polymerase Chain Reaction Registries Treatment Outcome Incidence Blotting, Western Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Prothrombin Time Follow-Up Studies Survival Analysis Drug Screening Assays, Antitumor Models, Biological Cell Count Hematologic Tests Survival Rate Immunohistochemistry Blood Coagulation Tests Antineoplastic Combined Chemotherapy Protocols Hematocrit Cohort Studies Inhibitory Concentration 50 Plateletpheresis Partial Thromboplastin Time Predictive Value of Tests Thrombelastography Risk Multivariate Analysis Risk Assessment Sensitivity and Specificity Combined Modality Therapy Reticulocyte Count Cluster Analysis Blood Preservation Drug Administration Schedule Case-Control Studies Neoplasm Staging Disease-Free Survival Blood Transfusion Odds Ratio Lymphocyte Count Disease Models, Animal Kaplan-Meier Estimate Xenograft Model Antitumor Assays Polymerase Chain Reaction Reproducibility of Results Clinical Trials as Topic Logistic Models Mean Platelet Volume Colony Count, Microbial Reference Values Drug Evaluation Enzyme-Linked Immunosorbent Assay Hematopoietic Stem Cell Transplantation Pilot Projects Chemotherapy, Adjuvant Transplantation, Heterologous Drug Therapy, Combination Blood Component Transfusion

Psychiatry and Psychology1

Phenomena and Processes51

Platelet Count Platelet Aggregation Platelet Adhesiveness Blood Cell Count Leukocyte Count Gene Expression Regulation, Neoplastic Bleeding Time Thrombopoiesis Cell Proliferation Cell Survival Hemostasis CD4 Lymphocyte Count Blood Coagulation Erythrocyte Count DNA Methylation Apoptosis Genetic Predisposition to Disease Signal Transduction Time Factors Mutation Drug Resistance, Neoplasm Prothrombin Time Cell Count Dose-Response Relationship, Drug Cell Movement Hematocrit Promoter Regions, Genetic Inhibitory Concentration 50 Partial Thromboplastin Time Base Sequence Risk Algorithms Sensitivity and Specificity Reticulocyte Count Gene Expression Hematopoiesis Genotype Odds Ratio Lymphocyte Count Platelet Activation Phosphorylation Mean Platelet Volume Cell Division Kinetics Fibrinolysis Cell Adhesion Phenotype Down-Regulation Polymorphism, Genetic Pregnancy Protein Binding

Disciplines and Occupations4

Immunohistochemistry Hematology Genomics Computational Biology

Anthropology, Education, Sociology and Social Phenomena1

National Cancer Institute (U.S.)

Technology, Industry, Agriculture1

Polyethylene Glycols

Information Science7

Registries Incidence Survival Rate Molecular Sequence Data Base Sequence Algorithms Databases, Genetic

Named Groups1

Health Care26

Retrospective Studies Risk Factors Prospective Studies Registries Treatment Outcome Incidence Follow-Up Studies Survival Analysis Survival Rate Cohort Studies Predictive Value of Tests Age Factors Risk Multivariate Analysis Risk Assessment Sensitivity and Specificity Cluster Analysis Case-Control Studies Disease-Free Survival National Cancer Institute (U.S.)Odds Ratio Kaplan-Meier Estimate Reproducibility of Results Clinical Trials as Topic Logistic Models Pilot Projects

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Platelet Count Blood Platelets Platelet Aggregation Thrombocytopenia Neoplasms Platelet Adhesiveness Platelet Transfusion Platelet Membrane Glycoproteins Thrombocytosis Blood Cell Count Platelet Factor 4 Cell Line, Tumor Purpura, Thrombocytopenic, Idiopathic Leukocyte Count Platelet Function Tests Breast Neoplasms Gene Expression Regulation, Neoplastic Megakaryocytes Platelet Glycoprotein GPIIb-IIIa Complex Antineoplastic Agents Platelet Glycoprotein GPIb-IX Complex Bleeding Time Platelet Activating Factor Lung Neoplasms Thrombopoietin Prostatic Neoplasms Purpura, Thrombocytopenic Ovarian Neoplasms Colonic Neoplasms Thrombin Prognosis Antigens, Human Platelet Early Detection of Cancer Fibrinogen Thrombopoiesis Splenectomy Gene Expression Profiling Cell Proliferation Adenosine Diphosphate Neoplasm Metastasis Neoplasm Invasiveness Thrombosis Tumor Markers, Biological Cell Survival Colorectal Neoplasms Retrospective Studies Neoplasm Proteins P-Selectin Risk Factors Hemostasis CD4 Lymphocyte Count Mice, Nude Blood Coagulation Erythrocyte Count Flow Cytometry RNA, Messenger Disease Progression Disseminated Intravascular Coagulation Prospective Studies DNA Methylation Apoptosis Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction von Willebrand Factor Signal Transduction Time Factors Registries Mutation Drug Resistance, Neoplasm Thrombocythemia, Essential Hemorrhage MicroRNAs Treatment Outcome HELLP Syndrome Cell Transformation, Neoplastic Blood Coagulation Disorders Incidence Blotting, Western Antigens, Neoplasm Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Carcinoma, Squamous Cell Prothrombin Time Follow-Up Studies Aspirin Receptors, Thrombopoietin Platelet Membrane Glycoprotein IIb Survival Analysis Drug Screening Assays, Antitumor Models, Biological Cell Count RNA, Small Interfering Tumor Cells, Cultured Stomach Neoplasms Dose-Response Relationship, Drug Hematologic Tests Survival Rate Adenocarcinoma Antibodies, Monoclonal Hypersplenism

No FAQ available that match "different cancer platelet count"